1-7 of 7
Gheath Alatrash
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer

Clinton Yam, Er-Yen Yen, Jeffrey T. Chang, Roland L. Bassett, Jr, Gheath Alatrash, Haven Garber, Lei Huo, Fei Yang, Anne V. Philips, Qing-Qing Ding, Bora Lim, Naoto T. Ueno, Kasthuri Kannan, Xiangjie Sun, Baohua Sun, Edwin Roger Parra Cuentas, William Fraser Symmans, Jason B. White, Elizabeth Ravenberg, Sahil Seth, Jennifer L. Guerriero, Gaiane M. Rauch, Senthil Damodaran, Jennifer K. Litton, Jennifer A. Wargo, Gabriel N. Hortobagyi, Andrew Futreal, Ignacio I. Wistuba, Ryan Sun, Stacy L. Moulder, Elizabeth A. Mittendorf
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (19): 5365–5375.
https://doi.org/10.1158/1078-0432.CCR-21-0144
Published: 01 October 2021
View article titled, Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer
Open the PDF for Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer

G. Travis Clifton, Diane Hale, Timothy J. Vreeland, Annelies T. Hickerson, Jennifer K. Litton, Gheath Alatrash, Rashmi K. Murthy, Na Qiao, Anne V. Philips, Jason J. Lukas, Jarrod P. Holmes, George E. Peoples, Elizabeth A. Mittendorf
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (11): 2515–2523.
https://doi.org/10.1158/1078-0432.CCR-19-2741
Published: 01 June 2020
View article titled, Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer
Open the PDF for Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes

Gheath Alatrash, Na Qiao, Mao Zhang, Madhushree Zope, Alexander A. Perakis, Pariya Sukhumalchandra, Anne V. Philips, Haven R. Garber, Celine Kerros, Lisa S. St. John, Maria R. Khouri, Hiep Khong, Karen Clise-Dwyer, Leonard P. Miller, Steve Wolpe, Willem W. Overwijk, Jeffrey J. Molldrem, Qing Ma, Elizabeth J. Shpall, Elizabeth A. Mittendorf
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (8): 2610–2620.
https://doi.org/10.1158/1078-0432.CCR-18-1527
Published: 15 April 2019
View article titled, Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes
Open the PDF for Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes in another window
Includes: Supplementary data
Journal Articles

Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma

Gheath Alatrash, Alexander A. Perakis, Celine Kerros, Haley L. Peters, Pariya Sukhumalchandra, Mao Zhang, Haroon Jakher, Madhushree Zope, Rebecca Patenia, Anna Sergeeva, Shuhua Yi, Ken H. Young, Anne V. Philips, Amanda M. Cernosek, Haven R. Garber, Na Qiao, Jinsheng Weng, Lisa S. St John, Sijie Lu, Karen Clise-Dwyer, Elizabeth A. Mittendorf, Qing Ma, Jeffrey J. Molldrem
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (14): 3386–3396.
https://doi.org/10.1158/1078-0432.CCR-17-2626
Published: 15 July 2018
View article titled, Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma
Open the PDF for Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Updated Results of Rituximab Pre- and Post-BEAM with or without 90Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell Lymphoma

Jad Chahoud, Dawen Sui, William D. Erwin, Alison M. Gulbis, Martin Korbling, Mingzhi Zhang, Sairah Ahmed, Gheath Alatrash, Paolo Anderlini, Stefan O. Ciurea, Betul Oran, Luis E. Fayad, Roland L. Bassett, Jr, Elias J. Jabbour, L. Jeffrey Medeiros, Homer A. Macapinlac, Ken H. Young, Issa F. Khouri
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (10): 2304–2311.
https://doi.org/10.1158/1078-0432.CCR-17-3561
Published: 14 May 2018
View article titled, Updated Results of Rituximab Pre- and Post-BEAM with or without <sup>90</sup>Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell Lymphoma
Open the PDF for Updated Results of Rituximab Pre- and Post-BEAM with or without <sup>90</sup>Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

A Novel HLA-A*0201 Restricted Peptide Derived from Cathepsin G Is an Effective Immunotherapeutic Target in Acute Myeloid Leukemia

Mao Zhang, Pariya Sukhumalchandra, Atim A. Enyenihi, Lisa S. St. John, Sally A. Hunsucker, Elizabeth A. Mittendorf, Anna Sergeeva, Kathryn Ruisaard, Zein Al-Atrache, Patricia A. Ropp, Haroon Jakher, Tania Rodriguez-Cruz, Gregory Lizee, Karen Clise-Dwyer, Sijie Lu, Jeffrey J. Molldrem, Gary L. Glish, Paul M. Armistead, Gheath Alatrash
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (1): 247–257.
https://doi.org/10.1158/1078-0432.CCR-12-2753
Published: 02 January 2013
View article titled, A Novel HLA-A*0201 Restricted Peptide Derived from Cathepsin G Is an Effective Immunotherapeutic Target in Acute Myeloid Leukemia
Open the PDF for A Novel HLA-A*0201 Restricted Peptide Derived from Cathepsin G Is an Effective Immunotherapeutic Target in Acute Myeloid Leukemia in another window
Includes: Supplementary data
Journal Articles

Targeting Human B-cell Malignancies through Ig Light Chain–Specific Cytotoxic T Lymphocytes

Jinsheng Weng, Soung-Chul Cha, Satoko Matsueda, Gheath Alatrash, Michael S. Popescu, Qing Yi, Jeffrey J. Molldrem, Michael Wang, Sattva S. Neelapu, Larry W. Kwak
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (18): 5945–5952.
https://doi.org/10.1158/1078-0432.CCR-11-0970
Published: 14 September 2011
View article titled, Targeting Human B-cell Malignancies through Ig Light Chain–Specific Cytotoxic T Lymphocytes
Open the PDF for Targeting Human B-cell Malignancies through Ig Light Chain–Specific Cytotoxic T Lymphocytes in another window